YD Bio YDES
NASDAQ YDES
$6.12 +0.20 (+3.38%)
At close: Oct 19, 2026 · 4:00 PM EDT

YD Bio (YDES) Payables (2024 - 2026)

Updated

YD Bio (YDES) recorded Payables of $333,411 in the quarter ended Jun 30, 2026, down 47.3% from $632,762 a year earlier.

Analysis

YD Bio (YDES) Payables (2024 - 2026) Analysis & Trends

As of Dec 31, 2025, YD Bio reported Payables of $437,859, up 140.1% from the prior year.

  • Across earlier years, Payables came in at $182,360 in the year ended Dec 31, 2024.
  • The figure for the quarter ended Jun 30, 2026 is the lowest quarterly Payables since the quarter ended Dec 31, 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Payables (Qtr)
1 Eli Lilly 1,109.83 Bn 1,078.42 Bn 19.71 Bn 6.11 Bn
2 Johnson & Johnson 610.61 Bn 529.14 Bn 17.26 Bn 20.92 Bn
3 AbbVie 500.66 Bn 473.77 Bn 12.70 Bn 33.30 Bn
4 Merck 354.64 Bn 309.02 Bn 12.21 Bn 5.96 Bn
5 Novartis Ag 291.14 Bn 255.13 Bn 11.24 Bn 4.26 Bn
6 Astrazeneca 254.18 Bn 227.87 Bn 12.86 Bn 22.89 Bn
7 Amgen 229.46 Bn 184.86 Bn 7.24 Bn 2.87 Bn
8 Gilead Sciences 190.33 Bn 164.53 Bn 6.22 Bn 674.00 Mn
9 Pfizer 167.92 Bn 114.57 Bn 10.94 Bn 7.03 Bn
10 YD Bio 417.66 Mn 405.39 Mn - 371,594.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 371,594.00
Dec 31, 2025 437,859.00
Jun 30, 2025 632,762.00
Dec 31, 2024 182,360.00
API Access

YD Bio Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=payables&ticker=YDES&period=max&api_key=YOUR_API_KEY